Pulse Biosciences Inc [PLSE] stock prices are down -4.91% to $17.61 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The PLSE shares have gain 21.28% over the last week, with a monthly amount glided 10.41%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Pulse Biosciences Inc [NASDAQ: PLSE] stock has seen the most recent analyst activity on July 07, 2025, when Oppenheimer initiated its Outperform rating and assigned the stock a price target of $22. Previously, Stephens started tracking the stock with Overweight rating on July 27, 2021, and set its price target to $28. On March 11, 2021, Maxim Group initiated with a Buy rating and assigned a price target of $40 on the stock. H.C. Wainwright reiterated its Buy rating and increased its price target to $40 on January 26, 2021. H.C. Wainwright upgraded its rating to a Buy and raised its price target to $16 on May 12, 2020. H.C. Wainwright downgraded its rating to Neutral for this stock on February 14, 2020, and downed its price target to $6. In a note dated February 25, 2019, H.C. Wainwright initiated a Buy rating and provided a target price of $27 on this stock.
The stock price of Pulse Biosciences Inc [PLSE] has been fluctuating between $13.77 and $25.00 over the past year. Pulse Biosciences Inc [NASDAQ: PLSE] shares were valued at $17.61 at the most recent close of the market.
Analyzing the PLSE fundamentals
Gross Profit Margin for this corporation currently stands at 0.17% with Operating Profit Margin at -43.41%, Pretax Profit Margin comes in at -40.88%, and Net Profit Margin reading is -40.88%. To continue investigating profitability, this company’s Return on Assets is posted at -0.57, Equity is -0.65 and Total Capital is -0.65. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.08.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It’s worth pointing out that Pulse Biosciences Inc [NASDAQ:PLSE]’s Current Ratio is 12.05. In addition, the Quick Ratio stands at 12.04 and the Cash Ratio stands at 11.85.
Transactions by insiders
Recent insider trading involved UECKER DARRIN, Chief Technology Officer, that happened on Sep 16 ’25 when 25000.0 shares were sold. Chief Technology Officer, UECKER DARRIN completed a deal on Sep 17 ’25 to sell 20000.0 shares. Meanwhile, Officer KEVIN DANAHY bought 25000.0 shares on Sep 18 ’25.
